Clinical Trial Update: QLS1410 in Participants With Uncontrolled Hypertension [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for QLS1410 in uncontrolled hypertension; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• QLS1410

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Hypertension (HTN) | Phase 2 | Status: NOT_YET_RECRUITING